Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 4.07599245 |
2 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.74631650 |
3 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70411160 |
4 | desmosome organization (GO:0002934) | 3.68091525 |
5 | cell communication involved in cardiac conduction (GO:0086065) | 3.66450914 |
6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.62987134 |
7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.51224335 |
8 | plasma membrane repair (GO:0001778) | 3.50892836 |
9 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.48292773 |
10 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.47303232 |
11 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.44923271 |
12 | myofibril assembly (GO:0030239) | 3.44915875 |
13 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.40765148 |
14 | regulation of synapse structural plasticity (GO:0051823) | 3.39029465 |
15 | regulation of membrane repolarization (GO:0060306) | 3.38502764 |
16 | cell communication by electrical coupling (GO:0010644) | 3.36988752 |
17 | carnitine shuttle (GO:0006853) | 3.36008521 |
18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.31952065 |
19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31438297 |
20 | cellular potassium ion homeostasis (GO:0030007) | 3.26922102 |
21 | sarcomere organization (GO:0045214) | 3.26731367 |
22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.25247069 |
23 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.24258732 |
24 | surfactant homeostasis (GO:0043129) | 3.20163483 |
25 | fatty acid transmembrane transport (GO:1902001) | 3.14848103 |
26 | glutamate secretion (GO:0014047) | 3.12972932 |
27 | hemidesmosome assembly (GO:0031581) | 3.11953279 |
28 | chemical homeostasis within a tissue (GO:0048875) | 3.11482677 |
29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.11434358 |
30 | cardiac conduction (GO:0061337) | 3.11332115 |
31 | cardiac muscle cell action potential (GO:0086001) | 3.08954409 |
32 | cardiac muscle contraction (GO:0060048) | 3.07774518 |
33 | L-amino acid import (GO:0043092) | 3.03199334 |
34 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.01931078 |
35 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.01772336 |
36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.99752384 |
37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.98110061 |
38 | neuronal action potential propagation (GO:0019227) | 2.95381412 |
39 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.93463497 |
40 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.89241806 |
41 | neuronal ion channel clustering (GO:0045161) | 2.89127420 |
42 | regulation of synaptic vesicle transport (GO:1902803) | 2.88864248 |
43 | locomotory exploration behavior (GO:0035641) | 2.87568378 |
44 | cAMP catabolic process (GO:0006198) | 2.87392796 |
45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86866951 |
46 | response to dietary excess (GO:0002021) | 2.86078504 |
47 | vocalization behavior (GO:0071625) | 2.85427887 |
48 | activation of protein kinase A activity (GO:0034199) | 2.84854965 |
49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.83121534 |
50 | regulation of sarcomere organization (GO:0060297) | 2.82651843 |
51 | cyclic nucleotide catabolic process (GO:0009214) | 2.80913643 |
52 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.79869985 |
53 | regulation of skeletal muscle contraction (GO:0014819) | 2.79780029 |
54 | gamma-aminobutyric acid transport (GO:0015812) | 2.76987207 |
55 | heart trabecula formation (GO:0060347) | 2.75634680 |
56 | cardiac muscle adaptation (GO:0014887) | 2.74580836 |
57 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.74580836 |
58 | muscle hypertrophy in response to stress (GO:0003299) | 2.74580836 |
59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72969395 |
60 | cellular response to epinephrine stimulus (GO:0071872) | 2.72427833 |
61 | synaptic vesicle maturation (GO:0016188) | 2.71753345 |
62 | cAMP biosynthetic process (GO:0006171) | 2.69952179 |
63 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.69591059 |
64 | regulation of sequestering of triglyceride (GO:0010889) | 2.68284132 |
65 | relaxation of cardiac muscle (GO:0055119) | 2.68064616 |
66 | negative regulation of vascular permeability (GO:0043116) | 2.67375181 |
67 | auditory behavior (GO:0031223) | 2.67071044 |
68 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.65609901 |
69 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.65540637 |
70 | actomyosin structure organization (GO:0031032) | 2.64172657 |
71 | lymphangiogenesis (GO:0001946) | 2.61953703 |
72 | regulation of female receptivity (GO:0045924) | 2.61233221 |
73 | synaptic vesicle exocytosis (GO:0016079) | 2.61030050 |
74 | neurotransmitter secretion (GO:0007269) | 2.60808174 |
75 | sodium ion export (GO:0071436) | 2.59964440 |
76 | regulation of cardioblast differentiation (GO:0051890) | 2.59754389 |
77 | central nervous system myelination (GO:0022010) | 2.56572027 |
78 | axon ensheathment in central nervous system (GO:0032291) | 2.56572027 |
79 | muscle hypertrophy (GO:0014896) | 2.56396237 |
80 | regulation of actin filament-based movement (GO:1903115) | 2.56161775 |
81 | cGMP-mediated signaling (GO:0019934) | 2.55695880 |
82 | potassium ion import (GO:0010107) | 2.53972160 |
83 | cellular sodium ion homeostasis (GO:0006883) | 2.53773268 |
84 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.52677503 |
85 | postsynaptic membrane organization (GO:0001941) | 2.52325086 |
86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51602663 |
87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.50961389 |
88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.50931662 |
89 | cardiac muscle cell development (GO:0055013) | 2.50708492 |
90 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.49689904 |
91 | carnitine transmembrane transport (GO:1902603) | 2.49588075 |
92 | establishment of nucleus localization (GO:0040023) | 2.49342007 |
93 | cardiac muscle hypertrophy (GO:0003300) | 2.49050358 |
94 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.48452807 |
95 | cardiac cell development (GO:0055006) | 2.47780561 |
96 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.47503959 |
97 | amino acid import (GO:0043090) | 2.46978948 |
98 | stress fiber assembly (GO:0043149) | 2.45638490 |
99 | response to epinephrine (GO:0071871) | 2.45636166 |
100 | striatum development (GO:0021756) | 2.45594870 |
101 | regulation of the force of heart contraction (GO:0002026) | 2.45535559 |
102 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.43079255 |
103 | striated muscle hypertrophy (GO:0014897) | 2.42059794 |
104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.41420382 |
105 | neurotransmitter uptake (GO:0001504) | 2.40923721 |
106 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.40827014 |
107 | fibroblast migration (GO:0010761) | 2.40818079 |
108 | membrane depolarization (GO:0051899) | 2.40242061 |
109 | potassium ion homeostasis (GO:0055075) | 2.40185838 |
110 | regulation of heart rate (GO:0002027) | 2.40099824 |
111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.39941239 |
112 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.39941239 |
113 | dendritic spine morphogenesis (GO:0060997) | 2.39757128 |
114 | cAMP metabolic process (GO:0046058) | 2.38409479 |
115 | striated muscle contraction (GO:0006941) | 2.38258315 |
116 | lymph vessel development (GO:0001945) | 2.37920987 |
117 | peripheral nervous system axon ensheathment (GO:0032292) | 2.37271643 |
118 | myelination in peripheral nervous system (GO:0022011) | 2.37271643 |
119 | positive regulation of sodium ion transport (GO:0010765) | 2.37237946 |
120 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.37167276 |
121 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.36675452 |
122 | regulation of vasculogenesis (GO:2001212) | 2.36467088 |
123 | synaptic transmission, glutamatergic (GO:0035249) | 2.35406754 |
124 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.35195934 |
125 | regulation of cell communication by electrical coupling (GO:0010649) | 2.35024074 |
126 | exploration behavior (GO:0035640) | 2.35004866 |
127 | muscle filament sliding (GO:0030049) | 2.34844678 |
128 | actin-myosin filament sliding (GO:0033275) | 2.34844678 |
129 | adult heart development (GO:0007512) | 2.34446391 |
130 | regulation of neurotransmitter transport (GO:0051588) | 2.33871398 |
131 | detection of calcium ion (GO:0005513) | 2.33655435 |
132 | cGMP metabolic process (GO:0046068) | 2.32994600 |
133 | regulation of neurotransmitter secretion (GO:0046928) | 2.32923145 |
134 | regulation of cardiac muscle contraction (GO:0055117) | 2.32641396 |
135 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.32193325 |
136 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.31879324 |
137 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.31782570 |
138 | membrane depolarization during action potential (GO:0086010) | 2.31437698 |
139 | amino-acid betaine transport (GO:0015838) | 2.30948968 |
140 | carnitine transport (GO:0015879) | 2.30948968 |
141 | triglyceride catabolic process (GO:0019433) | 2.30196833 |
142 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.29613694 |
143 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.28540111 |
144 | multicellular organismal signaling (GO:0035637) | 2.28069074 |
145 | tricarboxylic acid cycle (GO:0006099) | 2.27124101 |
146 | layer formation in cerebral cortex (GO:0021819) | 2.26827010 |
147 | regulation of heart contraction (GO:0008016) | 2.26348807 |
148 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.25026432 |
149 | response to caffeine (GO:0031000) | 2.23783509 |
150 | cell-substrate junction assembly (GO:0007044) | 2.23520713 |
151 | membrane repolarization (GO:0086009) | 2.23395725 |
152 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.22726662 |
153 | potassium ion export (GO:0071435) | 2.22343441 |
154 | nucleus localization (GO:0051647) | 2.22223566 |
155 | regulation of striated muscle contraction (GO:0006942) | 2.22047840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.72043614 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67585779 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37244409 |
4 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30033685 |
5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30033685 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27414235 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27232057 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.26281755 |
9 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.16433201 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08972411 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03512731 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02338750 |
13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99887737 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94455511 |
15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93861635 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93452210 |
17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93363478 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92656646 |
19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87869852 |
20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.79081466 |
21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78576156 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78266050 |
23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75538495 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69059609 |
25 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67497257 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67086763 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65183048 |
28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62605494 |
29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62325115 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55693175 |
31 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52165029 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50521367 |
33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50364919 |
34 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.44341967 |
35 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.44341967 |
36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44329761 |
37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42476273 |
38 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.42055041 |
39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36896614 |
40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34683341 |
41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34516667 |
42 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32668796 |
43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31413962 |
44 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29744394 |
45 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29296599 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28535395 |
47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28331724 |
48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.28290040 |
49 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28129878 |
50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25611700 |
51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25115311 |
52 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.24389432 |
53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24193922 |
54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22283874 |
55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21137734 |
56 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20813813 |
57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20338117 |
58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18939094 |
59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18301238 |
60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18112610 |
61 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16045868 |
62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14561844 |
63 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13656613 |
64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13544029 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12395739 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12254166 |
67 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11288323 |
68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11025935 |
69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10986371 |
70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10878879 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10745408 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10010852 |
73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09929347 |
74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09702455 |
75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09524129 |
76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08986258 |
77 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06671481 |
78 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06442604 |
79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05051471 |
80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04227447 |
81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03705761 |
82 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03361119 |
83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03286832 |
84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03179566 |
85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02361481 |
86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02010665 |
87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01804820 |
88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01802644 |
89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01551767 |
90 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00853678 |
91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00343607 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00156600 |
93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99936162 |
94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99921431 |
95 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98722455 |
96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97429692 |
97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96095855 |
98 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95787802 |
99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95636138 |
100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95208359 |
101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95119072 |
102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93156025 |
103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91611764 |
104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91581893 |
105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91195297 |
106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91103369 |
107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91086339 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90832234 |
109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90727728 |
110 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90659831 |
111 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.90601136 |
112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90484598 |
113 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90028529 |
114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90023309 |
115 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89492953 |
116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89196954 |
117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88709360 |
118 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88117748 |
119 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87277208 |
120 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87083332 |
121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86975063 |
122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86909026 |
123 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86857464 |
124 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85629879 |
125 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83792951 |
126 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83763029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 4.15856640 |
2 | MP0000751_myopathy | 3.69522454 |
3 | MP0004084_abnormal_cardiac_muscle | 3.35810831 |
4 | MP0004215_abnormal_myocardial_fiber | 3.34777046 |
5 | MP0005670_abnormal_white_adipose | 3.04206449 |
6 | MP0003646_muscle_fatigue | 3.00242047 |
7 | MP0005275_abnormal_skin_tensile | 2.62030411 |
8 | MP0004130_abnormal_muscle_cell | 2.61945489 |
9 | MP0004036_abnormal_muscle_relaxation | 2.55073746 |
10 | MP0010368_abnormal_lymphatic_system | 2.54869598 |
11 | MP0002822_catalepsy | 2.51660808 |
12 | MP0004859_abnormal_synaptic_plasticity | 2.49376116 |
13 | MP0005666_abnormal_adipose_tissue | 2.25915502 |
14 | MP0006138_congestive_heart_failure | 2.22003589 |
15 | MP0005330_cardiomyopathy | 2.20438474 |
16 | MP0004272_abnormal_basement_membrane | 2.15024235 |
17 | MP0002972_abnormal_cardiac_muscle | 2.09778423 |
18 | MP0005620_abnormal_muscle_contractility | 2.09011079 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.07962020 |
20 | MP0008775_abnormal_heart_ventricle | 1.92384468 |
21 | MP0004087_abnormal_muscle_fiber | 1.90608822 |
22 | MP0000749_muscle_degeneration | 1.87845446 |
23 | MP0005385_cardiovascular_system_phenoty | 1.87727153 |
24 | MP0001544_abnormal_cardiovascular_syste | 1.87727153 |
25 | MP0004484_altered_response_of | 1.84187608 |
26 | MP0002796_impaired_skin_barrier | 1.81370701 |
27 | MP0001968_abnormal_touch/_nociception | 1.80869871 |
28 | MP0003828_pulmonary_edema | 1.80146420 |
29 | MP0003137_abnormal_impulse_conducting | 1.80064344 |
30 | MP0005167_abnormal_blood-brain_barrier | 1.78098426 |
31 | MP0001879_abnormal_lymphatic_vessel | 1.77625633 |
32 | MP0003941_abnormal_skin_development | 1.76143196 |
33 | MP0004085_abnormal_heartbeat | 1.75672555 |
34 | MP0003950_abnormal_plasma_membrane | 1.71714039 |
35 | MP0001502_abnormal_circadian_rhythm | 1.70299673 |
36 | MP0005375_adipose_tissue_phenotype | 1.69662133 |
37 | MP0003690_abnormal_glial_cell | 1.63300219 |
38 | MP0006276_abnormal_autonomic_nervous | 1.61326336 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.59592010 |
40 | MP0000013_abnormal_adipose_tissue | 1.58142960 |
41 | MP0010630_abnormal_cardiac_muscle | 1.57794248 |
42 | MP0000750_abnormal_muscle_regeneration | 1.57752413 |
43 | MP0003879_abnormal_hair_cell | 1.57657959 |
44 | MP0005646_abnormal_pituitary_gland | 1.55550219 |
45 | MP0002638_abnormal_pupillary_reflex | 1.54924293 |
46 | MP0002734_abnormal_mechanical_nocicepti | 1.54198699 |
47 | MP0001440_abnormal_grooming_behavior | 1.53683614 |
48 | MP0001958_emphysema | 1.50484194 |
49 | MP0003705_abnormal_hypodermis_morpholog | 1.50199523 |
50 | MP0002876_abnormal_thyroid_physiology | 1.43602741 |
51 | MP0008438_abnormal_cutaneous_collagen | 1.41140848 |
52 | MP0003633_abnormal_nervous_system | 1.39175199 |
53 | MP0005551_abnormal_eye_electrophysiolog | 1.38650417 |
54 | MP0008961_abnormal_basal_metabolism | 1.38189197 |
55 | MP0001970_abnormal_pain_threshold | 1.35226125 |
56 | MP0003635_abnormal_synaptic_transmissio | 1.34497064 |
57 | MP0001984_abnormal_olfaction | 1.32930144 |
58 | MP0002909_abnormal_adrenal_gland | 1.32626969 |
59 | MP0002736_abnormal_nociception_after | 1.29923586 |
60 | MP0002106_abnormal_muscle_physiology | 1.29440815 |
61 | MP0005535_abnormal_body_temperature | 1.29436500 |
62 | MP0002733_abnormal_thermal_nociception | 1.27230855 |
63 | MP0005623_abnormal_meninges_morphology | 1.23199870 |
64 | MP0003045_fibrosis | 1.22589519 |
65 | MP0010234_abnormal_vibrissa_follicle | 1.21944374 |
66 | MP0004145_abnormal_muscle_electrophysio | 1.20600895 |
67 | MP0002127_abnormal_cardiovascular_syste | 1.18830568 |
68 | MP0003566_abnormal_cell_adhesion | 1.18675923 |
69 | MP0000759_abnormal_skeletal_muscle | 1.17283077 |
70 | MP0000003_abnormal_adipose_tissue | 1.16658003 |
71 | MP0005369_muscle_phenotype | 1.13724454 |
72 | MP0001177_atelectasis | 1.13347332 |
73 | MP0000566_synostosis | 1.13223960 |
74 | MP0002735_abnormal_chemical_nociception | 1.10192934 |
75 | MP0004043_abnormal_pH_regulation | 1.08040807 |
76 | MP0004924_abnormal_behavior | 1.07501891 |
77 | MP0005386_behavior/neurological_phenoty | 1.07501891 |
78 | MP0002067_abnormal_sensory_capabilities | 1.07005256 |
79 | MP0003631_nervous_system_phenotype | 1.06370125 |
80 | MP0005503_abnormal_tendon_morphology | 1.04971500 |
81 | MP0002063_abnormal_learning/memory/cond | 1.04490333 |
82 | MP0002332_abnormal_exercise_endurance | 1.04102278 |
83 | MP0000579_abnormal_nail_morphology | 1.02559200 |
84 | MP0002557_abnormal_social/conspecific_i | 1.01821300 |
85 | MP0010329_abnormal_lipoprotein_level | 1.01452631 |
86 | MP0001664_abnormal_digestion | 1.01261530 |
87 | MP0002108_abnormal_muscle_morphology | 1.01004472 |
88 | MP0004782_abnormal_surfactant_physiolog | 1.00329252 |
89 | MP0004510_myositis | 0.99791371 |
90 | MP0009745_abnormal_behavioral_response | 0.99140759 |
91 | MP0002254_reproductive_system_inflammat | 0.99132276 |
92 | MP0002234_abnormal_pharynx_morphology | 0.98371404 |
93 | MP0003880_abnormal_central_pattern | 0.97105120 |
94 | MP0002269_muscular_atrophy | 0.96379872 |
95 | MP0002133_abnormal_respiratory_system | 0.94256796 |
96 | MP0005388_respiratory_system_phenotype | 0.94256796 |
97 | MP0004233_abnormal_muscle_weight | 0.93434561 |
98 | MP0003283_abnormal_digestive_organ | 0.90757148 |
99 | MP0004147_increased_porphyrin_level | 0.90166166 |
100 | MP0001486_abnormal_startle_reflex | 0.89928468 |
101 | MP0001986_abnormal_taste_sensitivity | 0.89214490 |
102 | MP0003279_aneurysm | 0.87932731 |
103 | MP0003011_delayed_dark_adaptation | 0.87920094 |
104 | MP0005448_abnormal_energy_balance | 0.87597765 |
105 | MP0001501_abnormal_sleep_pattern | 0.82945387 |
106 | MP0005595_abnormal_vascular_smooth | 0.82768225 |
107 | MP0008569_lethality_at_weaning | 0.82346413 |
108 | MP0005423_abnormal_somatic_nervous | 0.81011063 |
109 | MP0002971_abnormal_brown_adipose | 0.80978551 |
110 | MP0001485_abnormal_pinna_reflex | 0.80570958 |
111 | MP0005334_abnormal_fat_pad | 0.79749089 |
112 | MP0005645_abnormal_hypothalamus_physiol | 0.79209084 |
113 | MP0009046_muscle_twitch | 0.78548105 |
114 | MP0004270_analgesia | 0.77708878 |
115 | MP0002066_abnormal_motor_capabilities/c | 0.77351920 |
116 | MP0000230_abnormal_systemic_arterial | 0.76858770 |
117 | MP0000747_muscle_weakness | 0.75816454 |
118 | MP0002272_abnormal_nervous_system | 0.75096817 |
119 | MP0001905_abnormal_dopamine_level | 0.74974086 |
120 | MP0003959_abnormal_lean_body | 0.73608857 |
121 | MP0000266_abnormal_heart_morphology | 0.73510628 |
122 | MP0000343_altered_response_to | 0.73305602 |
123 | MP0000767_abnormal_smooth_muscle | 0.71480541 |
124 | MP0009115_abnormal_fat_cell | 0.71286510 |
125 | MP0002295_abnormal_pulmonary_circulatio | 0.71262337 |
126 | MP0005501_abnormal_skin_physiology | 0.71185659 |
127 | MP0000534_abnormal_ureter_morphology | 0.71038073 |
128 | MP0005165_increased_susceptibility_to | 0.70958588 |
129 | MP0002060_abnormal_skin_morphology | 0.70814490 |
130 | MP0002064_seizures | 0.69703678 |
131 | MP0005253_abnormal_eye_physiology | 0.69698413 |
132 | MP0004858_abnormal_nervous_system | 0.68620275 |
133 | MP0002090_abnormal_vision | 0.68423497 |
134 | MP0001849_ear_inflammation | 0.67161207 |
135 | MP0006072_abnormal_retinal_apoptosis | 0.66905565 |
136 | MP0002572_abnormal_emotion/affect_behav | 0.65789543 |
137 | MP0005409_darkened_coat_color | 0.64861697 |
138 | MP0004885_abnormal_endolymph | 0.63576087 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 5.82958546 |
2 | Atrial fibrillation (HP:0005110) | 4.74635845 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 4.68312345 |
4 | Ventricular tachycardia (HP:0004756) | 4.52944751 |
5 | Primary atrial arrhythmia (HP:0001692) | 4.44120871 |
6 | Supraventricular arrhythmia (HP:0005115) | 4.19592484 |
7 | Supraventricular tachycardia (HP:0004755) | 4.18309046 |
8 | Muscle fiber splitting (HP:0003555) | 4.15295355 |
9 | Prolonged QT interval (HP:0001657) | 4.09612092 |
10 | Syncope (HP:0001279) | 3.97733295 |
11 | Exercise-induced myalgia (HP:0003738) | 3.84039523 |
12 | Ventricular fibrillation (HP:0001663) | 3.80712942 |
13 | Bundle branch block (HP:0011710) | 3.78203421 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 3.75456483 |
15 | Febrile seizures (HP:0002373) | 3.74604955 |
16 | Increased connective tissue (HP:0009025) | 3.68562540 |
17 | Abnormality of the calf musculature (HP:0001430) | 3.47350700 |
18 | Atonic seizures (HP:0010819) | 3.44082125 |
19 | Lipoatrophy (HP:0100578) | 3.32680743 |
20 | Calf muscle hypertrophy (HP:0008981) | 3.27980880 |
21 | Papilledema (HP:0001085) | 3.27389055 |
22 | Difficulty running (HP:0009046) | 3.22203997 |
23 | Atrioventricular block (HP:0001678) | 3.21491315 |
24 | Ventricular arrhythmia (HP:0004308) | 3.19398824 |
25 | Abnormal EKG (HP:0003115) | 3.16244879 |
26 | Diplopia (HP:0000651) | 3.13577469 |
27 | Abnormality of binocular vision (HP:0011514) | 3.13577469 |
28 | Heart block (HP:0012722) | 3.08000214 |
29 | Congenital stationary night blindness (HP:0007642) | 3.07001202 |
30 | Hemiplegia (HP:0002301) | 3.04801976 |
31 | Pigmentary retinal degeneration (HP:0001146) | 3.01415011 |
32 | Abnormal atrioventricular conduction (HP:0005150) | 2.99499448 |
33 | Broad metatarsal (HP:0001783) | 2.97200414 |
34 | Central scotoma (HP:0000603) | 2.95791981 |
35 | Progressive cerebellar ataxia (HP:0002073) | 2.88714657 |
36 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.85079739 |
37 | Subaortic stenosis (HP:0001682) | 2.85079739 |
38 | Hemiparesis (HP:0001269) | 2.83987108 |
39 | Epileptic encephalopathy (HP:0200134) | 2.83457120 |
40 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82969755 |
41 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.77347868 |
42 | Abnormal eating behavior (HP:0100738) | 2.75948143 |
43 | Myokymia (HP:0002411) | 2.74061543 |
44 | Dysdiadochokinesis (HP:0002075) | 2.73290876 |
45 | Hyperventilation (HP:0002883) | 2.72759442 |
46 | Gaze-evoked nystagmus (HP:0000640) | 2.72626862 |
47 | Focal motor seizures (HP:0011153) | 2.66738461 |
48 | Exercise-induced muscle cramps (HP:0003710) | 2.66398779 |
49 | Myotonia (HP:0002486) | 2.65752972 |
50 | Dilated cardiomyopathy (HP:0001644) | 2.64539859 |
51 | Acanthosis nigricans (HP:0000956) | 2.62535671 |
52 | Type 1 muscle fiber predominance (HP:0003803) | 2.60152780 |
53 | Generalized tonic-clonic seizures (HP:0002069) | 2.59639123 |
54 | Postural instability (HP:0002172) | 2.52907595 |
55 | Scotoma (HP:0000575) | 2.44389531 |
56 | Myoglobinuria (HP:0002913) | 2.43407249 |
57 | Limb dystonia (HP:0002451) | 2.42010712 |
58 | Palpitations (HP:0001962) | 2.39121788 |
59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37435469 |
60 | Dysmetric saccades (HP:0000641) | 2.33773469 |
61 | Genetic anticipation (HP:0003743) | 2.29877308 |
62 | Obstructive sleep apnea (HP:0002870) | 2.28987776 |
63 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27969802 |
64 | Anxiety (HP:0000739) | 2.26658501 |
65 | Dialeptic seizures (HP:0011146) | 2.26484653 |
66 | Absence seizures (HP:0002121) | 2.24255162 |
67 | Milia (HP:0001056) | 2.22158554 |
68 | EMG: myopathic abnormalities (HP:0003458) | 2.20725666 |
69 | Poor eye contact (HP:0000817) | 2.20230672 |
70 | Polycythemia (HP:0001901) | 2.18262697 |
71 | Increased circulating renin level (HP:0000848) | 2.17954791 |
72 | Hematochezia (HP:0002573) | 2.11733725 |
73 | Pheochromocytoma (HP:0002666) | 2.10964355 |
74 | Truncal ataxia (HP:0002078) | 2.10911519 |
75 | Action tremor (HP:0002345) | 2.09489238 |
76 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08663522 |
77 | Decreased circulating renin level (HP:0003351) | 2.08037114 |
78 | Bradycardia (HP:0001662) | 2.07847482 |
79 | Atrophic scars (HP:0001075) | 2.06857674 |
80 | Cerebral aneurysm (HP:0004944) | 2.06780554 |
81 | Difficulty climbing stairs (HP:0003551) | 2.06166556 |
82 | Broad-based gait (HP:0002136) | 2.05780659 |
83 | Abnormal drinking behavior (HP:0030082) | 2.04267068 |
84 | Polydipsia (HP:0001959) | 2.04267068 |
85 | Prominent supraorbital ridges (HP:0000336) | 2.03816301 |
86 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03552011 |
87 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03552011 |
88 | Aplasia involving bones of the extremities (HP:0009825) | 2.03552011 |
89 | Palmoplantar keratoderma (HP:0000982) | 2.02986431 |
90 | Lower limb amyotrophy (HP:0007210) | 2.02872957 |
91 | Abnormality of the periventricular white matter (HP:0002518) | 2.01524598 |
92 | Asymmetric septal hypertrophy (HP:0001670) | 2.01374036 |
93 | Subcapsular cataract (HP:0000523) | 2.01181150 |
94 | Pulmonary artery stenosis (HP:0004415) | 2.00572174 |
95 | Hyperkalemia (HP:0002153) | 1.99681802 |
96 | Abnormality of the ischium (HP:0003174) | 1.97626856 |
97 | Accelerated skeletal maturation (HP:0005616) | 1.97133319 |
98 | Distal lower limb amyotrophy (HP:0008944) | 1.96676236 |
99 | Ankle contracture (HP:0006466) | 1.95896690 |
100 | Follicular hyperkeratosis (HP:0007502) | 1.94592699 |
101 | Intention tremor (HP:0002080) | 1.93426673 |
102 | Blue irides (HP:0000635) | 1.92576600 |
103 | Distal lower limb muscle weakness (HP:0009053) | 1.91617214 |
104 | Mesangial abnormality (HP:0001966) | 1.91326315 |
105 | Ankle clonus (HP:0011448) | 1.90906702 |
106 | Facial diplegia (HP:0001349) | 1.90578416 |
107 | Left ventricular hypertrophy (HP:0001712) | 1.89811363 |
108 | Steppage gait (HP:0003376) | 1.89644433 |
109 | Torticollis (HP:0000473) | 1.88565025 |
110 | EMG: neuropathic changes (HP:0003445) | 1.87146930 |
111 | Proximal amyotrophy (HP:0007126) | 1.87070668 |
112 | Polar cataract (HP:0010696) | 1.86932760 |
113 | Oligomenorrhea (HP:0000876) | 1.86713719 |
114 | Scapular winging (HP:0003691) | 1.86216536 |
115 | Focal seizures (HP:0007359) | 1.85922779 |
116 | Frequent falls (HP:0002359) | 1.85301531 |
117 | Ulnar claw (HP:0001178) | 1.84436137 |
118 | Annular pancreas (HP:0001734) | 1.83842400 |
119 | Spinal rigidity (HP:0003306) | 1.82060595 |
120 | Inability to walk (HP:0002540) | 1.81788698 |
121 | Depressed nasal tip (HP:0000437) | 1.81676786 |
122 | Hamartoma of the eye (HP:0010568) | 1.81189499 |
123 | Hip contracture (HP:0003273) | 1.80478717 |
124 | Abnormality of the renal cortex (HP:0011035) | 1.80165424 |
125 | Hypercortisolism (HP:0001578) | 1.79539531 |
126 | Shallow orbits (HP:0000586) | 1.79033772 |
127 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.78897077 |
128 | Hypotrichosis (HP:0001006) | 1.77145437 |
129 | Lymphangioma (HP:0100764) | 1.75601820 |
130 | Sudden cardiac death (HP:0001645) | 1.74879167 |
131 | Adrenal overactivity (HP:0002717) | 1.73802400 |
132 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73179826 |
133 | Hypokalemic alkalosis (HP:0001949) | 1.72846851 |
134 | Metabolic alkalosis (HP:0200114) | 1.72653811 |
135 | Spastic tetraparesis (HP:0001285) | 1.72644920 |
136 | Chorioretinal atrophy (HP:0000533) | 1.72326953 |
137 | Impaired smooth pursuit (HP:0007772) | 1.70634883 |
138 | Tachypnea (HP:0002789) | 1.69954940 |
139 | Absent speech (HP:0001344) | 1.69373217 |
140 | Hyperaldosteronism (HP:0000859) | 1.68065269 |
141 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67535110 |
142 | Dysmetria (HP:0001310) | 1.67009412 |
143 | Status epilepticus (HP:0002133) | 1.66813363 |
144 | Plantar hyperkeratosis (HP:0007556) | 1.65689872 |
145 | Lip pit (HP:0100267) | 1.64450649 |
146 | Overgrowth (HP:0001548) | 1.64220586 |
147 | Mutism (HP:0002300) | 1.64097996 |
148 | Neonatal death (HP:0003811) | 1.62291301 |
149 | Testicular atrophy (HP:0000029) | 1.62185158 |
150 | Long toe (HP:0010511) | 1.61130916 |
151 | Limited hip movement (HP:0008800) | 1.59213474 |
152 | Foot dorsiflexor weakness (HP:0009027) | 1.59096662 |
153 | Bronchomalacia (HP:0002780) | 1.58954015 |
154 | Abnormality of the foot musculature (HP:0001436) | 1.58786774 |
155 | Rapidly progressive (HP:0003678) | 1.58212317 |
156 | Abnormality of macular pigmentation (HP:0008002) | 1.58096908 |
157 | Muscular dystrophy (HP:0003560) | 1.57680911 |
158 | Neck muscle weakness (HP:0000467) | 1.57530603 |
159 | Conjunctival hamartoma (HP:0100780) | 1.56459226 |
160 | Resting tremor (HP:0002322) | 1.56009934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 4.44201112 |
2 | EPHA4 | 3.56121636 |
3 | FRK | 2.97422270 |
4 | LMTK2 | 2.67246169 |
5 | RIPK1 | 2.30394629 |
6 | DMPK | 2.27943066 |
7 | CAMK1D | 2.24728406 |
8 | NTRK3 | 2.24653124 |
9 | PHKG2 | 2.23429234 |
10 | PHKG1 | 2.23429234 |
11 | TRIB3 | 2.16390372 |
12 | PRKD3 | 2.16171812 |
13 | TTN | 2.11048831 |
14 | CAMK1G | 1.94459395 |
15 | MYLK | 1.94256004 |
16 | LATS1 | 1.77641913 |
17 | PDK4 | 1.77240010 |
18 | PDK3 | 1.77240010 |
19 | STK38 | 1.71012691 |
20 | MAP4K2 | 1.66268035 |
21 | STK39 | 1.64159071 |
22 | LATS2 | 1.63505186 |
23 | PINK1 | 1.63291198 |
24 | MAPK13 | 1.62607676 |
25 | FER | 1.60999243 |
26 | DAPK2 | 1.58063776 |
27 | OBSCN | 1.56117764 |
28 | MAP3K9 | 1.46083242 |
29 | EPHB2 | 1.41788424 |
30 | MAPKAPK5 | 1.34648072 |
31 | CASK | 1.34237728 |
32 | KSR2 | 1.32778307 |
33 | UHMK1 | 1.31749429 |
34 | TAOK1 | 1.29119791 |
35 | PDGFRA | 1.28549636 |
36 | CCNB1 | 1.21660918 |
37 | GRK1 | 1.19688596 |
38 | DDR2 | 1.11908784 |
39 | MAP3K4 | 1.10730511 |
40 | PDK2 | 1.10522976 |
41 | PTK2B | 1.09806699 |
42 | TGFBR2 | 1.09094447 |
43 | MARK1 | 1.07909549 |
44 | TRPM7 | 1.06058148 |
45 | PAK6 | 1.06041046 |
46 | CAMKK1 | 1.03732473 |
47 | MAP3K2 | 1.03494614 |
48 | PKN1 | 1.02784056 |
49 | CAMK2B | 1.02015687 |
50 | RIPK4 | 1.01815485 |
51 | AKT3 | 1.01395087 |
52 | PRKCH | 1.01011724 |
53 | STK38L | 1.00942820 |
54 | SGK2 | 1.00316857 |
55 | MARK2 | 0.99343774 |
56 | CAMK1 | 0.98002221 |
57 | PRKD1 | 0.97199429 |
58 | NEK1 | 0.97004464 |
59 | FGFR2 | 0.95983185 |
60 | TAOK3 | 0.95765248 |
61 | SGK3 | 0.95548016 |
62 | MAP3K6 | 0.95346363 |
63 | MAPK15 | 0.94388220 |
64 | KIT | 0.92337921 |
65 | BMPR1B | 0.92328369 |
66 | PIK3CA | 0.91027821 |
67 | SIK1 | 0.90129968 |
68 | NTRK2 | 0.89061347 |
69 | RET | 0.86702609 |
70 | PRKCG | 0.85505302 |
71 | CDC42BPA | 0.84487609 |
72 | CAMKK2 | 0.83300698 |
73 | OXSR1 | 0.83258736 |
74 | SGK494 | 0.81913894 |
75 | SGK223 | 0.81913894 |
76 | PRKAA2 | 0.80747484 |
77 | ROCK1 | 0.77948768 |
78 | INSRR | 0.77880400 |
79 | STK24 | 0.77469837 |
80 | FGFR3 | 0.76506919 |
81 | PAK3 | 0.74428526 |
82 | CAMK4 | 0.73232520 |
83 | MAPK12 | 0.71992529 |
84 | EEF2K | 0.71629542 |
85 | ADRBK1 | 0.71422620 |
86 | CDK5 | 0.71295213 |
87 | PRKCE | 0.70591056 |
88 | MAP3K7 | 0.70057494 |
89 | PDGFRB | 0.69913347 |
90 | PRKAA1 | 0.68846449 |
91 | PNCK | 0.68702599 |
92 | SGK1 | 0.67620421 |
93 | PDPK1 | 0.67269142 |
94 | PRKG1 | 0.66569189 |
95 | MAP2K4 | 0.65847905 |
96 | MINK1 | 0.64895362 |
97 | PLK2 | 0.64630246 |
98 | ZAK | 0.62504994 |
99 | MAPK4 | 0.61621903 |
100 | CAMK2G | 0.61032364 |
101 | STK11 | 0.60850411 |
102 | ADRBK2 | 0.60588932 |
103 | MAPK10 | 0.60266732 |
104 | MUSK | 0.59579363 |
105 | NEK6 | 0.59167904 |
106 | TYRO3 | 0.58958503 |
107 | MAP3K1 | 0.58852596 |
108 | MAP2K1 | 0.57927817 |
109 | CAMK2A | 0.57245299 |
110 | NLK | 0.57158596 |
111 | PRKD2 | 0.55800958 |
112 | MAPKAPK3 | 0.55658605 |
113 | CAMK2D | 0.55608777 |
114 | PKN2 | 0.53610771 |
115 | MAP2K7 | 0.52372051 |
116 | PRKACA | 0.51535664 |
117 | FGFR1 | 0.51314285 |
118 | DAPK1 | 0.51265840 |
119 | DYRK1A | 0.50017837 |
120 | WNK1 | 0.47949177 |
121 | MST1R | 0.46533889 |
122 | KSR1 | 0.46217013 |
123 | RPS6KA2 | 0.45158174 |
124 | FES | 0.44898210 |
125 | EPHA3 | 0.43888250 |
126 | NTRK1 | 0.42672867 |
127 | PDK1 | 0.42259007 |
128 | RPS6KA3 | 0.40752420 |
129 | MAP3K3 | 0.39576493 |
130 | MAPK7 | 0.39091493 |
131 | GRK5 | 0.37837920 |
132 | ILK | 0.37477940 |
133 | WNK4 | 0.37313312 |
134 | PRKACG | 0.37155851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.49488081 |
2 | Phototransduction_Homo sapiens_hsa04744 | 2.48527538 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.21958183 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19203002 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.11695490 |
6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.01910226 |
7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.99132084 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92838621 |
9 | Renin secretion_Homo sapiens_hsa04924 | 1.88422357 |
10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82540512 |
11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64942280 |
12 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.63091460 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 1.62807839 |
14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53293246 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.52248842 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50995038 |
17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49625708 |
18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.49533535 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46058712 |
20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.45441776 |
21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.41616026 |
22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41455240 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40653915 |
24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40193450 |
25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39272725 |
26 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.39148227 |
27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38724987 |
28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37446582 |
29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35781122 |
30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25820643 |
31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23004148 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.22848293 |
33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.22325519 |
34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21278064 |
35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21179308 |
36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.19796587 |
37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18630815 |
38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17230098 |
39 | Focal adhesion_Homo sapiens_hsa04510 | 1.15170550 |
40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14629330 |
41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12493300 |
42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12401936 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09609455 |
44 | Taste transduction_Homo sapiens_hsa04742 | 1.08627721 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.07995264 |
46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07638543 |
47 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06530881 |
48 | Adherens junction_Homo sapiens_hsa04520 | 1.04903883 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04689087 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04363250 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97939052 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96682191 |
53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96432254 |
54 | Gap junction_Homo sapiens_hsa04540 | 0.96019037 |
55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94447794 |
56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94337658 |
57 | Bile secretion_Homo sapiens_hsa04976 | 0.94089670 |
58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94083272 |
59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93352041 |
60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92580970 |
61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92516919 |
62 | Axon guidance_Homo sapiens_hsa04360 | 0.91949878 |
63 | Insulin resistance_Homo sapiens_hsa04931 | 0.91159612 |
64 | Melanogenesis_Homo sapiens_hsa04916 | 0.90484787 |
65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90157166 |
66 | Tight junction_Homo sapiens_hsa04530 | 0.89214714 |
67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88370380 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87952122 |
69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86720952 |
70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85903837 |
71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85532338 |
72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81840885 |
73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80200422 |
74 | Glioma_Homo sapiens_hsa05214 | 0.79041394 |
75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77880386 |
76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77382106 |
77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76295292 |
78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75382725 |
79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75332971 |
80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74650363 |
81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73733519 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73313408 |
83 | Long-term depression_Homo sapiens_hsa04730 | 0.71113704 |
84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70447089 |
85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69822990 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69702025 |
87 | Amoebiasis_Homo sapiens_hsa05146 | 0.68028500 |
88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67388032 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66289659 |
90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65380082 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64985336 |
92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64056902 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63945346 |
94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63041381 |
95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61443528 |
96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60938911 |
97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60761281 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60326376 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59480560 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.59378817 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56627906 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56232139 |
103 | Platelet activation_Homo sapiens_hsa04611 | 0.56042717 |
104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55239928 |
105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54445478 |
106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51501271 |
107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51402072 |
108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50675373 |
109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50167550 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49198560 |
111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48332312 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48260862 |
113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48250098 |
114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47510952 |
115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47247675 |
116 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46907296 |
117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43204933 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.42300095 |
119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42184330 |
120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41669510 |
121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40868635 |
122 | Endocytosis_Homo sapiens_hsa04144 | 0.40721248 |
123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40493442 |
124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37695637 |